Potomac Analytics' Logo

Broker-Dealers on SEC Form D for AEGIS CAPITAL CORP.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 71-80 out of 175 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
AEGIS CAPITAL CORP.15007BIO BLAST PHARMA LTD.159681202/13/2014D$4,750,000$4,750,000
AEGIS CAPITAL CORP.15007Aerami Therapeutics Holdings, Inc.165084006/17/2020D$15,000,000$4,608,000
AEGIS CAPITAL CORP.15007Nxt-ID, Inc.156682607/28/2016D$4,500,000$4,500,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Aerospace II187703208/05/2021D$5,000,000$4,465,000
AEGIS CAPITAL CORP.15007Matinas BioPharma Holdings, Inc.158255408/12/2016D$8,000,000$4,400,290
AEGIS CAPITAL CORP.15007INTERCLOUD SYSTEMS, INC.112872510/20/2014D$4,345,000$4,345,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Medtech VII193535406/28/2022D$20,000,000$4,314,000
AEGIS CAPITAL CORP.15007CVSL INC.140308511/25/2015D$4,000,000$4,000,000
AEGIS CAPITAL CORP.15007Aegis Special Situations QP Fund LLC - Series Agritech II184948403/09/2021D$10,000,000$4,000,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Medtech VIII192879605/13/2022D$7,000,000$3,805,000

175 Results

Display: